Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
about
Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vectorLiver-targeted gene therapy: Approaches and challengesGenetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotypeIntravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits.Engineering viral vectors to subvert the airway defense response.GENE THERAPY FOR THE TREATMENT OF PITUITARY TUMORSImmune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsOral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trialImmunological hurdles to lung gene therapy.Correction of the UDP-glucuronosyltransferase gene defect in the gunn rat model of crigler-najjar syndrome type I with a chimeric oligonucleotideIn vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector.Gene therapy for liver enzyme deficiencies: what have we learned from models for Crigler-Najjar and tyrosinemia?Efficient, repeated adenovirus-mediated gene transfer in mice lacking both tumor necrosis factor alpha and lymphotoxin alpha.Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.Nonviral gene delivery to human breast cancer cells by targeted Ad5 penton proteins.Role of NK1.1+ and AsGm-1+ cells in oral immunoregulation of experimental colitis.Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis.Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.Adenoviral-mediated gene transfer to mouse salivary glands.Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo.
P2860
Q24555782-E6EF2219-99F5-4077-9434-65BD74C1FE97Q28085748-4AB917C5-6C3B-40AD-B0EF-C9DCB0A7ABD8Q28140057-4A796733-4063-4D6E-9159-69045C74146CQ33331929-67D77D49-8955-496C-A150-D08F03EF1296Q33643006-A9C9D67F-FE92-4AED-81F6-2F8523C3FDBCQ33674877-2CF7B19D-0E78-42FA-8B23-AC17315D8BD8Q33782487-422A7580-9DAF-46D4-85C1-733DB7DD288FQ33817535-59163767-6624-4BBD-A964-69BAF18E5F40Q35010988-8496D0DF-F191-4ED3-B096-27DA34AF0B08Q35091006-543CF691-71EA-4A2F-A376-9F4F8EE0EA03Q35620922-127DF275-EAD8-4DCD-9A53-DB9CC560573DQ36825641-50DF2104-1805-4ACC-937B-48732D33AD24Q37346064-3F354061-325C-470F-9056-7EE3E2EAD150Q39582787-4564735F-316E-4056-AB85-31CEF9A46815Q39601057-19D29D1B-3A4F-4B76-B133-23B8BC8EE0B5Q43709939-79F4D43C-569E-4806-BA67-FBDC025582E3Q43824684-A23E9AFE-E9EF-4818-AB57-65BDD998FB76Q43861765-1F30A9D8-E083-40EA-95E0-F14AE254DCC3Q44455571-2FA80C43-64DA-4AE7-995D-BCDA7521A7E4Q44616432-43CA9F73-CD76-4A0C-83D4-ED178D633441Q45733307-E1B810F4-1736-40C6-ACD0-5EDC45ACFFC1Q45866155-2F45CB3A-B523-4B84-B03F-6786EBF7E886Q45885418-9DF7D488-6705-4B28-827E-BD1DA8C6C004
P2860
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@en
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@nl
type
label
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@en
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@nl
prefLabel
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@en
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@nl
P2093
P2860
P356
P1476
Oral tolerization to adenovira ...... ecombinant adenoviral vectors.
@en
P2093
G Droguett
J R Chowdhury
M S Horwitz
N R Chowdhury
P2860
P304
P356
10.1172/JCI119238
P407
P577
1997-03-01T00:00:00Z